- Home
- Products
- Customized FluoroAb™
- FGFR2
- Anti-FGFR2 MAb (Clone 18)-iFluor® 460 Succinimidyl Ester
Anti-FGFR2 MAb (Clone 18)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8555)
- TARGET
- ANTIBODY
- DYE
- Name
- FGFR2
- Alternative Names
- Fibroblast Growth Factor Receptor 2; Keratinocyte Growth Factor Receptor; Bacteria-Expressed Kinase; EC 2.7.10.1; K-SAM; KGFR; BEK; Protein Tyrosine Kinase; Receptor Like 14; BEK Fibroblast Growth Factor Receptor; Craniofacial Dysostosis 1; Jackson-Weiss Syndrome; Pfeiffer Syndrome; Crouzon Syndrome; CD332 Antigen;
- Overview
- The protein encoded by this gene is a member of the fibroblast growth factor receptor family, where amino acid sequence is highly conserved between members and throughout evolution. FGFR family members differ from one another in their ligand affinities and tissue distribution. A full-length representative protein consists of an extracellular region, composed of three immunoglobulin-like domains, a single hydrophobic membrane-spanning segment and a cytoplasmic tyrosine kinase domain. The extracellular portion of the protein interacts with fibroblast growth factors, setting in motion a cascade of downstream signals, ultimately influencing mitogenesis and differentiation. This particular family member is a high-affinity receptor for acidic, basic and or keratinocyte growth factor, depending on the isoform. Mutations in this gene are associated with Crouzon syndrome, Pfeiffer syndrome, Craniosynostosis, Apert syndrome, Jackson-Weiss syndrome, Beare-Stevenson cutis gyrata syndrome, Saethre-Chotzen syndrome, and syndromic craniosynostosis. Multiple alternatively spliced transcript variants encoding different isoforms have been noted for this gene. [provided by RefSeq, Jan 2009]
- Overview
- Humanized Anti-FGFR2 IgG1-kappa (Clone 18)
- Species Reactivity
- Human
- Name
- iFluor® 460 Succinimidyl Ester
- Color
- Green
- Excitation⁄Emission (nm)
- 468/493
- Detection method
- Fluorescent
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for WJY0-LS8555. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-059 | Anti-FGFR2-sulfo-SMCC-DM1 ADC-9 | sulfo-SMCC (sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-l-carbox late) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-055 | Anti-FGFR2-sulfo-SMCC-DM1 ADC-5 | sulfo-SMCC (sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-l-carbox late) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-062 | Anti-FGFR2-sulfo-SMCC-DM1 ADC-12 | sulfo-SMCC (sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-l-carbox late) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-058 | Anti-FGFR2-sulfo-SMCC-DM1 ADC-8 | sulfo-SMCC (sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-l-carbox late) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
| ADC-W-065 | Anti-FGFR2-sulfo-SMCC-DM1 ADC-15 | sulfo-SMCC (sulfosuccinimidyl 4-(N-maleimidomethyl) cyclohexane-l-carbox late) | DM1 (N2’-Deacetyl-N2’-(3-mercapto-1-oxopropyl)maytansine) |
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-IL17RA MAb (Clone 2)-iFluor® 430 Succinimidyl Ester (CAT#: WJY0-LS3699)
- Anti-LTA MAb (Clone 4)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12150)
- Anti-CXCR4 MAb (Clone 4)-iFluor® 440 Succinimidyl Ester (CAT#: WJY0-LS5585)
- Anti-CD80 MAb (Clone 4)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15064)
- Anti-PDCD1 MAb (Clone 18)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS9155)
- Anti-MS4A1 MAb (Clone 20)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS16272)
- anti-CD70 antibody-iFluor 594 (CAT#: ADC-FL-890)
- Anti-CA9 MAb (Clone 3)-iFluor® 460 Succinimidyl Ester (CAT#: WJY0-LS8166)
- Anti-CD3E MAb (Clone 17)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2672)
- Bectumomab-iFluor 568 (CAT#: ADC-FL-439)
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
